Dr Parvaiz Ahmad Koul appointed director of SKIMS

Koul will replace Dr A G Ahangar who retired on Friday.

Published On 2022-01-01 03:45 GMT   |   Update On 2022-01-01 03:45 GMT

Srinagar: The Jammu and Kashmir administration on Friday appointed Dr Parvaiz Ahmad Koul as the director of the Sher-e-Kashmir Institute of Medical Sciences (SKIMS) here.Koul's appointment will take effect from January 1, according to an order.Also Read: NMC announces one-time provisional relaxation for appointment, promotion of faculty, Details"As approved by the Chairman, Governing Body,...

Login or Register to read the full article

Srinagar: The Jammu and Kashmir administration on Friday appointed Dr Parvaiz Ahmad Koul as the director of the Sher-e-Kashmir Institute of Medical Sciences (SKIMS) here.

Koul's appointment will take effect from January 1, according to an order.

Also Read: NMC announces one-time provisional relaxation for appointment, promotion of faculty, Details

"As approved by the Chairman, Governing Body, SKIMS, Soura, Srinagar (Hon'ble Lieutenant Governor, J&K), Dr. Parvaiz Ahmad Koul, Ex-Professor and Head of Department, General Medicine, SKIMS, is hereby appointed as Director, Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Soura, Srinagar with effect from 01.01.2022," the order read.

Koul will replace Dr A G Ahangar who retired on Friday.

Also Read: Andhra appoints new members of State Medical Council

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News